Kashif Rashid
CIK: 0001725900
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Aug 10, 2026SGHT
Sight Sciences, Inc.
Award(A)Direct181.8K shares- - Apr 3, 2025NVRO
NEVRO CORP
Disposition(D)Direct477.7K shares- - Mar 20, 2025NVRO
NEVRO CORP
Tax Payment(F)Direct611 shares at avg. $5.78$4K - Mar 20, 2025NVRO
NEVRO CORP
Award(A)Direct1.1K shares- - Mar 7, 2025NVRO
NEVRO CORP
Tax Payment(F)Direct1.8K shares at avg. $5.77$10K - Mar 7, 2025NVRO
NEVRO CORP
Tax Payment(F)Direct15.1K shares at avg. $5.77$87K - Mar 2, 2025NVRO
NEVRO CORP
Tax Payment(F)Direct944 shares at avg. $5.72$5K - Feb 28, 2025NVRO
NEVRO CORP
Tax Payment(F)Direct825 shares at avg. $5.72$5K - Feb 28, 2025NVRO
NEVRO CORP
Award(A)Direct742 shares- - Feb 28, 2025NVRO
NEVRO CORP
Tax Payment(F)Direct392 shares at avg. $5.72$2K - Jan 4, 2025NVRO
NEVRO CORP
Tax Payment(F)Direct527 shares at avg. $3.71$2K - Dec 7, 2024NVRO
NEVRO CORP
Tax Payment(F)Direct1.8K shares at avg. $4.19$7K - Nov 28, 2024NVRO
NEVRO CORP
Tax Payment(F)Direct816 shares at avg. $4.58$4K - Oct 4, 2024NVRO
NEVRO CORP
Tax Payment(F)Direct479 shares at avg. $4.97$2K - Sep 7, 2024NVRO
NEVRO CORP
Tax Payment(F)Direct1.8K shares at avg. $5.18$9K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 |  SGHT Sight Sciences, Inc. | Award(A) | 181,818 | - | $0 | Direct |
| Apr 3, 2025 |  NVRO NEVRO CORP | Disposition(D) | 477,738 | - | - | Direct |
| Mar 20, 2025 | NVRO NEVRO CORP | Tax Payment(F) | 611 | $5.78 | $3,532 | Direct |
| Mar 20, 2025 | NVRO NEVRO CORP | Award(A) | 1,136 | - | - | Direct |
| Mar 7, 2025 | NVRO NEVRO CORP | Tax Payment(F) | 1,758 | $5.77 | $10,144 | Direct |
| Mar 7, 2025 | NVRO NEVRO CORP | Tax Payment(F) | 15,136 | $5.77 | $87,335 | Direct |
| Mar 2, 2025 | NVRO NEVRO CORP | Tax Payment(F) | 944 | $5.72 | $5,400 | Direct |
| Feb 28, 2025 | NVRO NEVRO CORP | Tax Payment(F) | 825 | $5.72 | $4,719 | Direct |
| Feb 28, 2025 | NVRO NEVRO CORP | Award(A) | 742 | - | - | Direct |
| Feb 28, 2025 | NVRO NEVRO CORP | Tax Payment(F) | 392 | $5.72 | $2,242 | Direct |
| Jan 4, 2025 | NVRO NEVRO CORP | Tax Payment(F) | 527 | $3.71 | $1,955 | Direct |
| Dec 7, 2024 | NVRO NEVRO CORP | Tax Payment(F) | 1,759 | $4.19 | $7,370 | Direct |
| Nov 28, 2024 | NVRO NEVRO CORP | Tax Payment(F) | 816 | $4.58 | $3,737 | Direct |
| Oct 4, 2024 | NVRO NEVRO CORP | Tax Payment(F) | 479 | $4.97 | $2,381 | Direct |
| Sep 7, 2024 | NVRO NEVRO CORP | Tax Payment(F) | 1,759 | $5.18 | $9,112 | Direct |
1-15 of 15 transactions
About Rashid Kashif
Rashid Kashif (SEC CIK 0001725900) files insider reports with the SEC as Chief Legal Officer of Sight Sciences, Inc. (SGHT) and SVP, Corp Dev and CLO of NEVRO CORP (NVRO).
Signal8 holds 11 ownership filings by Rashid Kashif (1 Form 3, 10 Form 4), filed between Sep 10, 2024 and Aug 18, 2026. Those filings report 15 transactions, from Sep 7, 2024 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rashid Kashif's filings is in MENLO PARK, CA.
Recent filings by Rashid Kashif
- Aug 10, 2026: Grant or award of SGHT shares (Form 4, code A).
- Apr 3, 2025: Disposition to issuer transaction of NVRO shares (Form 4, code D).
- Mar 20, 2025: Tax withholding of NVRO shares (Form 4, code F).
- Mar 20, 2025: Grant or award of NVRO shares (Form 4, code A).
- Mar 7, 2025: Tax withholdings of NVRO shares (2 lines, Form 4, code F).
Other insiders filing for Sight Sciences, Inc. (SGHT)
- Taylor Brenton, EVP, Operations & R&D
- Bauerlein Alison, Chief Operating Officer
- Rodberg James, Chief Financial Officer
- Badawi David, Chief Technology Officer
- Badawi Paul, President and CEO
- HAYDEN JEREMY B., Chief Legal Officer